Achaete-scute homologue-1 (ASH1) stimulates migration of lung cancer cells through Cdk5/p35 pathway

Molecular Biology of the Cell

Volumn 23, Issue 15, 2012, Pages 2856-2866

  Demelash, Abeba ^a   Rudrabhatla, Parvathi ^b   Pant, Harish C ^b   Wang, Xiaoyang ^a   Amin, Niranjana D ^b   McWhite, Claire D ^a   Naizhen, Xu ^a   Linnoila, R Ilona ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACHAETE SCUTE HOMOLOG 1; CYCLIN DEPENDENT KINASE 5; PROTEIN P35; ROSCOVITINE; SHORT HAIRPIN RNA; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER CELL; CANCER CELL CULTURE; CELL INVASION; CELL MIGRATION; CONTROLLED STUDY; EMBRYO; ENZYME ACTIVITY; FETUS; GENE EXPRESSION; GENE SILENCING; HUMAN; HUMAN CELL; LUNG ADENOCARCINOMA; MOUSE; NEUROSECRETORY CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION;

ADENOCARCINOMA; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; CYCLIN-DEPENDENT KINASE 5; DNA-BINDING PROTEINS; GENE EXPRESSION REGULATION, NEOPLASTIC; HEK293 CELLS; HUMANS; LUNG NEOPLASMS; NEOPLASM INVASIVENESS; NERVE TISSUE PROTEINS; PURINES; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTORS;

EID: 84864755117     PISSN: 10591524     EISSN: 19394586     Source Type: Journal    
DOI: 10.1091/mbc.E10-12-1010     Document Type: Article

References (49)

1. Amin ND, Albers W, Pant HC (2002). Cyclin-dependent kinase 5 (cdk5) activation requires interaction with three domains of p35. J Neurosci Res 67, 354-362.
2. Borges M, Linnoila RI, van de Velde HJ, Chen H, Nelkin BD, Mabry M, Baylin SB, Ball DW (1997). An achaete-scute homologue essential for neuroendocrine differentiation in the lung. Nature 386, 852-855.
3. Bremnes RM, Veve R, Hirsch FR, Franklin WA (2002). The E-cadherin cell-cell adhesion complex and lung cancer invasion, metastasis, and prognosis. Lung Cancer 36, 115-124.
4. Castro DS et al. (2011). A novel function of the proneural factor Ascl1 in progenitor proliferation identified by genome-wide characterization of its targets. Gene Dev 25, 930-945.
5. Chambers AF, Groom AC, MacDonald IC (2002). Dissemination and growth of cancer cells in metastatic sites. Nat Rev Cancer 2, 563-572.
6. Daniel RJ, Groves RW (2002). Increased migration of murine keratinocytes under hypoxia is mediated by induction of urokinase plasminogen activator. J Invest Dermatol 119, 1304-1309.
7. Dhavan R, Tsai LH (2001). A decade of CDK5. Nat Rev Mol Cell Biol 2, 749-759.
8. Eggers JP et al. (2011). Cyclin-dependent kinase 5 is amplified and over-expressed in pancreatic cancer and activated by mutant K-Ras. Clinical Cancer Res 17, 6140-6150.
9. Feldmann G, Mishra A, Hong SM, Bisht S, Strock CJ, Ball DW, Goggins M, Maitra A, Nelkin BD (2010). Inhibiting the cyclin-dependent kinase CDK5 blocks pancreatic cancer formation and progression through the suppression of Ras-Ral signaling. Cancer Res 70, 4460-4469.
10. Fu X, Choi YK, Qu D, Yu Y, Cheung NS, Qi RZ (2006). Identification of nuclear import mechanisms for the neuronal Cdk5 activator. J Biol Chem 281, 39014-39021.
11. Gao C, Negash S, Guo HT, Ledee D, Wang HS, Zelenka P (2002). CDK5 regulates cell adhesion and migration in corneal epithelial cells. Mol Cancer Res 1, 12-24.
12. Ge W et al. (2006). Coupling of cell migration with neurogenesis by proneural bHLH factors. Proc Natl Acad Sci USA 103, 1319-1324.
13. Goodyear S, Sharma MC (2007). Roscovitine regulates invasive breast cancer cell (MDA-MB231) proliferation and survival through cell cycle regulatory protein cdk5. Exp Mol Pathol 82, 25-32.
14. Guillemot F, Lo LC, Johnson JE, Auerbach A, Anderson DJ, Joyner AL (1993). Mammalian achaete-scute homolog 1 is required for the early development of olfactory and autonomic neurons. Cell 75, 463-476.
15. Huang C, Rajfur Z, Yousefi N, Chen Z, Jacobson K, Ginsberg MH (2009). Talin phosphorylation by Cdk5 regulates Smurf1-mediated talin head ubiquitylation and cell migration. Nat Cell Biol 11, 624-630.
16. Jensen-Taubman S, Steinberg SM, Linnoila RI (1998). Bronchiolization of the alveoli in lung cancer: pathology, patterns of differentiation and oncogene expression. Int J Cancer 75, 489-496.
17. Jensen-Taubman S, Wang XY, Linnoila RI (2010). Achaete-scute homologue-1 tapers neuroendocrine cell differentiation in lungs after exposure to naphthalene. Toxicol Sci 117, 238-248.
18. Jiang T, Collins BJ, Jin N, Watkins DN, Brock MV, Matsui W, Nelkin BD, Ball DW (2009). Achaete-scute complex homologue 1 regulates tumor-initiating capacity in human small cell lung cancer. Cancer Res 69, 845-854.
19. Kuo HS, Hsu FN, Chiang MC, You SC, Chen MC, Lo MJ, Lin H (2009). The role of Cdk5 in retinoic acid-induced apoptosis of cervical cancer cell line. Chin J Physiol 52, 23-30.
20. Lagace DC, Benavides DR, Kansy JW, Mapelli M, Greengard P, Bibb JA, Eisch AJ (2008). Cdk5 is essential for adult hippocampal neurogenesis. Proc Natl Acad Sci USA 105, 18567-18571.
21. Lew J, Huang QQ, Qi Z, Winkfein RJ, Aebersold R, Hunt T, Wang JH (1994). A brain-specific activator of cyclin-dependent kinase 5. Nature 371, 423-426.
22. Liebl J, Weitensteiner SB, Vereb G, Takacs L, Fuerst R, Vollmar AM, Zahler S (2010). Cyclin dependent kinase 5 (Cdk5) regulates endothelial cell migration and angiogenesis. J Biol Chem 285, 35932-35943.
23. Lilja L, Yang SN, Webb DL, Juntti-Berggren L, Berggren PO, Bark C (2001). Cyclin-dependent kinase 5 promotes insulin exocytosis. J Biol Chem 276, 34199-34205.
24. Lin H, Chen MC, Chiu CY, Song YM, Lin SY (2007). Cdk5 regulates STAT3 activation and cell proliferation in medullary thyroid carcinoma cells. J Biol Chem 282, 2776-2784.
25. Lin H, Juang JL, Wang PS (2004). Involvement of Cdk5/p25 in digoxin-triggered prostate cancer cell apoptosis. J Biol Chem 279, 29302-29307.
26. Linnoila RI (1996). Spectrum of neuroendocrine differentiation in lung cancer cell lines featured by cytomorphology, markers, and their corresponding tumors. J Cell Biochem Suppl 24, 92-106.
27. Linnoila RI, Zhao B, DeMayo JL, Nelkin BD, Baylin SB, DeMayo FJ, Ball DW (2000). Constitutive achaete-scute homologue-1 promotes airway dysplasia and lung neuroendocrine tumors in transgenic mice. Cancer Res 60, 4005-4009.
28. Liu JL, Wang XY, Huang BX, Zhu F, Zhang RG, Wu G (2011). Expression of CDK5/p35 in resected patients with non-small cell lung cancer: relation to prognosis. Med Oncol 28, 673-678.
29. Liu Y et al. (2009). Ablation of p120-catenin enhances invasion and metastasis of human lung cancer cells. Cancer Sci 100, 441-448.
30. Meuwissen R, Linn SC, Linnoila RI, Zevenhoven J, Mooi WJ, Berns A (2003). Induction of small cell lung cancer by somatic inactivation of both Trp53 and Rb1 in a conditional mouse model. Cancer Cell 4, 181-189.
31. Miki M, Ball DW, Linnoila RI (2012). Insights into the achaete-scute homolog-1 gene (hASH1) in normal and neoplastic human lung. Lung Cancer 75, 58-65.
32. Moersig W, Horn S, Hilker M, Mayer E, Oelert H (2002). Transfection of E-cadherin cDNA in human lung tumor cells reduces invasive potential of tumors. Thorac Cardiovasc Surg 50, 45-48.
33. Nikolic M, Dudek H, Kwon YT, Ramos YFM, Tsai LH (1996). The cdk5/p35 kinase is essential for neurite outgrowth during neuronal differentiation. Genes Dev 10, 816-825.
34. Nishikawa E et al. (2011). miR-375 is activated by ASH1 and inhibits YAP1 in a lineage dependent manner in lung cancer. Cancer Res 71, 6165-6173.
35. Osada H, Tomida S, Yatabe Y, Tatematsu Y, Takeuchi T, Murakami H, Kondo Y, Sekido Y, Takahashi T (2008). Roles of achaete-scute homologue 1 in DKK1 and E-cadherin repression and neuroendocrine differentiation in lung cancer. Cancer Res 68, 1647-1655.
36. Sriuranpong V, Borges MW, Strock CL, Nakakura EK, Watkins DN, Blaumueller CM, Nelkin BD, Ball DW (2002). Notch signaling induces rapid degradation of achaete-scute homolog 1. Mol Cell Biol 22, 3129-3139.
37. Strock CJ, Park JI, Nakakura EK, Bova GS, Isaacs JT, Ball DW, Nelkin BD (2006). Cyclin-dependent kinase 5 activity controls cell motility and metastatic potential of prostate cancer cells. Cancer Res 66, 7509-7515.
38. Tripathi BK, Zelenka PS (2009). Cdk5-dependent regulation of Rho activity, cytoskeletal contraction, and epithelial cell migration via suppression of Src and p190RhoGAP. Mol Cell Biol 29, 6488-6499.
39. Tripathi BK, Zelenka PS (2010). Cdk5: A regulator of epithelial cell adhesion and migration. Cell Adh Migr 4, 333-336.
40. Tsai LH, Delalle I, Caviness VS, Jr., Chae T, Harlow E (1994). p35 is a neural-specific regulatory subunit of cyclin-dependent kinase 5. Nature 371, 419-423.
41. Ubeda M, Kemp DM, Habener JF (2004). Glucose-induced expression of the cyclin-dependent protein kinase 5 activator p35 involved in Alzheimer's disease regulates insulin gene transcription in pancreatic-cells. Endocrinology 145, 3023-3031.
42. Wang XY, Dakir el H, Naizhen X, Jensen-Taubman SM, DeMayo FJ, Linnoila RI (2007). Achaete-scute homolog-1 linked to remodeling and preneoplasia of pulmonary epithelium. Lab Invest 87, 527-539.
43. Wang XY, Demelash A, Kim H, Jensen-Taubman S, Dakir el H, Ozbun L, Birrer MJ, Linnoila RI (2009). Matrilysin-1 mediates bronchiolization of alveoli, a potential premalignant change in lung cancer. Am J Pathol 175, 592-604.
44. Wang XY, Penalva LO, Yuan H, Linnoila RI, Lu J, Okano H, Glazer RI (2010). Musashi1 regulates breast tumor cell proliferation and is a prognostic indicator of poor survival. Mol Cancer 9, 221.
45. Xie Z, Tsai LH (2004). Cdk5 phosphorylation of FAK regulates centrosome-associated miocrotubules and neuronal migration. Cell Cycle 3, 108-110.
46. Zelenka PS (2004). Regulation of cell adhesion and migration in lens development. Int J Dev Biol 48, 857-865.
47. Zhang J, Cicero SA, Wang L, Romito-Digiacomo RR, Yang Y, Herrup K (2008). Nuclear localization of Cdk5 is a key determinant in the postmitotic state of neurons. Proc Natl Acad Sci USA 105, 8772-8777.
48. Zheng YL, Hu YF, Zhang A, Wang W, Li B, Amin N, Grant P, Pant HC (2010). Overexpression of p35 in Min6 pancreatic beta cells induces a stressed neuron-like apoptosis. J Neurol Sci 299, 101-107.
49. Zheng YL, Kesavapany S, Gravell M, Hamilton RS, Schubert M, Amin N, Albers W, Grant P, Pant HC (2005). A Cdk5 inhibitory peptide reduces tau hyperphosphorylation and apoptosis in neurons. EMBO J 24, 209-220.